BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21595874)

  • 1. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.
    Kabeer BS; Raja A; Raman B; Thangaraj S; Leportier M; Ippolito G; Girardi E; Lagrange PH; Goletti D
    BMC Infect Dis; 2011 May; 11():135. PubMed ID: 21595874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
    Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
    J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
    Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
    Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?
    Goletti D; Raja A; Syed Ahamed Kabeer B; Rodrigues C; Sodha A; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
    PLoS One; 2010 Sep; 5(9):e12577. PubMed ID: 20830287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.
    Sauzullo I; Mengoni F; Lichtner M; Massetti AP; Rossi R; Iannetta M; Marocco R; Del Borgo C; Soscia F; Vullo V; Mastroianni CM
    PLoS One; 2009; 4(4):e5187. PubMed ID: 19365543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy.
    Latorre I; Altet N; de Souza-Galvão M; Ruiz-Manzano J; Lacoma A; Prat C; Pérez M; Ausina V; Domínguez J
    Scand J Infect Dis; 2012 Mar; 44(3):161-7. PubMed ID: 21923628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment.
    Hong JY; Lee HJ; Kim SY; Chung KS; Kim EY; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Cho SN; Kang YA
    J Infect; 2014 Mar; 68(3):252-8. PubMed ID: 24247066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.
    Feng JY; Pan SW; Huang SF; Chen YY; Lin YY; Su WJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
    Oliver BG; Elliott JH; Price P; Phillips M; Cooper DA; French MA
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):287-92. PubMed ID: 22732467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.
    Delogu G; Chiacchio T; Vanini V; Butera O; Cuzzi G; Bua A; Molicotti P; Zanetti S; Lauria FN; Grisetti S; Magnavita N; Fadda G; Girardi E; Goletti D
    PLoS One; 2011 Mar; 6(3):e18315. PubMed ID: 21479248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis.
    Ruhwald M; Dominguez J; Latorre I; Losi M; Richeldi L; Pasticci MB; Mazzolla R; Goletti D; Butera O; Bruchfeld J; Gaines H; Gerogianni I; Tuuminen T; Ferrara G; Eugen-Olsen J; Ravn P;
    Tuberculosis (Edinb); 2011 May; 91(3):260-7. PubMed ID: 21459676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.
    Goletti D; Carrara S; Mayanja-Kizza H; Baseke J; Mugerwa MA; Girardi E; Toossi Z
    BMC Infect Dis; 2008 Jan; 8():11. PubMed ID: 18226199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects.
    Kabeer BS; Sikhamani R; Raja A
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):236-43. PubMed ID: 21996360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.